Medications that are commonly used to treat diabetes and help with weight loss may also have unexpected benefits for mental health, according to a large new study published in The Lancet Psychiatry.
These medicines, known as GLP-1 receptor agonists, include well-known drugs such as semaglutide, which are widely used today for managing type 2 diabetes and obesity.
Diabetes and obesity are long-term health conditions that affect millions of people worldwide. Both conditions are closely linked to mental health problems. People living with obesity or diabetes often experience depression, anxiety, and lower quality of life.
At the same time, people with mental health disorders are more likely to develop physical conditions like diabetes. This two-way relationship has made researchers very interested in understanding how treatments for one condition might affect the other.
The new study was carried out by researchers from the University of Eastern Finland, Karolinska Institutet in Sweden, and Griffith University in Australia. It used a large amount of real-world data from Swedish national health registers.
In total, nearly 100,000 people were included in the study, and more than 20,000 of them had used GLP-1 medications. The researchers followed these individuals over a long period, from 2009 to 2022, to see how their health changed over time.
The findings were striking. People who used GLP-1 medications had fewer hospital visits and took less time off work due to mental health problems. The strongest results were seen with semaglutide.
During the time when people were using semaglutide, their risk of needing hospital care or taking sick leave for psychiatric reasons was 42% lower compared to times when they were not using these medications.
The study also showed large reductions in specific mental health conditions. The risk of depression was 44% lower, and the risk of anxiety disorders was 38% lower during periods of semaglutide use. These are very meaningful differences, as depression and anxiety are among the most common mental health problems worldwide.
In addition to mood-related conditions, the researchers found that these medications were linked to a lower risk of substance use problems. Hospital care and sick leave related to substance use disorders were 47% lower during periods when people were taking semaglutide. The study also found a reduced risk of suicidal behavior among users of GLP-1 medications.
Researchers say these results were not entirely unexpected, but the size of the effect was surprising. Previous studies had already suggested that GLP-1 drugs might reduce alcohol use, which could in turn improve mood and mental health. However, this study showed a much stronger link than earlier research.
The exact reason why these medications may improve mental health is still not fully understood. One possible explanation is that losing weight can improve self-confidence and body image, which may reduce depression and anxiety. Better control of blood sugar levels in people with diabetes may also improve overall well-being.
Another possible explanation involves the brain. Scientists believe that GLP-1 medications may affect the brain’s reward system, which plays a role in mood, motivation, and addictive behaviors. If these drugs change how the brain responds to rewards, they may help reduce cravings and improve emotional balance.
It is important to note that this study was based on health records, which means it shows a strong connection but cannot prove a direct cause. Other factors may also play a role. Even so, the large size of the study and the long follow-up period make the findings important and worth further investigation.
Overall, this research suggests that GLP-1 medications may offer benefits beyond weight loss and blood sugar control. They may also help reduce the burden of mental health problems and improve quality of life for many people.
At the same time, more research is needed to understand exactly how these effects happen and whether they apply to all patients. Future studies, especially controlled clinical trials, will help confirm these findings and guide doctors in using these medications more effectively.
In summary, this study provides strong evidence that GLP-1 medications, especially semaglutide, are linked to better mental health outcomes. This is an exciting development, as it suggests that one type of treatment could support both physical and mental health at the same time.
From a critical perspective, while the results are very promising, it is important to remember that the study does not prove cause and effect. The improvements in mental health may be partly due to indirect factors such as weight loss, improved lifestyle, or reduced alcohol use.
In addition, the data comes from one country, which may limit how widely the findings can be applied. However, the large sample size and consistent results across different mental health outcomes make the findings strong and meaningful.
Overall, the study opens an important new direction for research and highlights the potential of these medications to improve both body and mind.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and to people with diabetes, some fruits are better than others.
For more health information, please see recent studies that low calorie diets may help reverse diabetes, and 5 vitamins that may prevent complication in diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
